Middle cerebral artery velocity changes during transfusion in sickle cell anemia.
Authors:
- 1 November 1994
- journal article
- abstracts
- Published by Wolters Kluwer Health in Stroke
- Vol. 25 (11) , 2153-2158
Abstract
Sickle cell disease is associated with cerebral hyperemia, which is therapeutically reduced by transfusion; however, the process of transfusion-induced cerebral perfusion changes has heretofore not been observed. We document the acute changes of intracranial arterial velocity in 10 patients (7 with strokes, 3 without) undergoing transfusion therapy using transcranial Doppler ultrasonography. Middle cerebral artery velocities were bilaterally measured every 30 minutes for the duration of transfusion (4 to 5 hours). Regional cerebral blood flow was quantified in 5 of these patients before the transfusion and 24 hours later by the 133Xe technique. Velocities in stroke-associated vessels (64.33 +/- 18.65 cm/s; n = 6) were significantly lower than in uninfarcted territories (99.54 +/- 27.39 cm/s; n = 13), and both types of vessels showed a robust reduction of blood flow velocities during transfusion. The rates of reduction were not significantly different as a function of prior stroke but did correlate with pretransfusion velocities and with the rise in hematocrit (multiple r = .887, P < .001). These reductions occurred rapidly within the first 3 hours of transfusion. Velocities attained at the end of transfusion were maintained in the hour after transfusion and the next day. We conclude that transfusion induces rapid changes in cerebral hemodynamics that are related to pretransfusion velocities and a rise in hematocrit. Transcranial Doppler provides a safe, simple, and noninvasive technique of monitoring these changes and may provide a means of making therapeutic decisions regarding transfusion therapy in patients with sickle cell anemia.Keywords
This publication has 22 references indexed in Scilit:
- Effects of total hemoglobin and hemoglobin S concentration on cerebral blood flow during transfusion therapy to prevent stroke in sickle cell disease.Stroke, 1994
- The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell DiseaseNew England Journal of Medicine, 1992
- Less intensive long-term transfusion therapy for sickle cell anemia and cerebrovascular accidentThe Journal of Pediatrics, 1992
- High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell diseaseThe Journal of Pediatrics, 1991
- Cerebral Vessel Stenosis in Sickle Cell DiseaseJournal of Pediatric Hematology/Oncology, 1990
- Is Chronic Transfusion Necessary to Prevent Recurrent Stroke in Children with Sickle Cell Disease?Annals of the New York Academy of Sciences, 1989
- THE EFFECT OF BLOOD TRANSFUSION ON CEREBRAL BLOOD‐FLOW IN PRETERM INFANTS: A DOPPLER STUDYDevelopmental Medicine & Child Neurology, 1988
- Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemiaThe Journal of Pediatrics, 1983
- Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidentsThe Journal of Pediatrics, 1980
- Transfusion therapy for cerebrovascular abnormalities in sickle cell diseaseThe Journal of Pediatrics, 1976